These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
482 related articles for article (PubMed ID: 37545498)
21. Tissue-resident memory T cells in the era of (Neo) adjuvant melanoma management. Plunkett KR; Armitage JD; Inderjeeth AJ; McDonnell AM; Waithman J; Lau PKH Front Immunol; 2022; 13():1048758. PubMed ID: 36466880 [TBL] [Abstract][Full Text] [Related]
22. CD49a Identifies Polyfunctional Memory CD8 T Cell Subsets that Persist in the Lungs After Influenza Infection. Reilly EC; Sportiello M; Emo KL; Amitrano AM; Jha R; Kumar ABR; Laniewski NG; Yang H; Kim M; Topham DJ Front Immunol; 2021; 12():728669. PubMed ID: 34566986 [TBL] [Abstract][Full Text] [Related]
25. Targeting Resident Memory T Cells for Cancer Immunotherapy. Blanc C; Hans S; Tran T; Granier C; Saldman A; Anson M; Oudard S; Tartour E Front Immunol; 2018; 9():1722. PubMed ID: 30100906 [TBL] [Abstract][Full Text] [Related]
26. CD8+CD103+ tissue-resident memory T cells convey reduced protective immunity in cutaneous squamous cell carcinoma. Lai C; Coltart G; Shapanis A; Healy C; Alabdulkareem A; Selvendran S; Theaker J; Sommerlad M; Rose-Zerilli M; Al-Shamkhani A; Healy E J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33479027 [TBL] [Abstract][Full Text] [Related]
27. Cancer-specific tissue-resident memory T-cells express ZNF683 in colorectal cancer. Kitakaze M; Uemura M; Hara T; Chijimatsu R; Motooka D; Hirai T; Konno M; Okuzaki D; Sekido Y; Hata T; Ogino T; Takahashi H; Miyoshi N; Ofusa K; Mizushima T; Eguchi H; Doki Y; Ishii H Br J Cancer; 2023 May; 128(10):1828-1837. PubMed ID: 36869093 [TBL] [Abstract][Full Text] [Related]
28. Limited Predictive or Prognostic Role of Tumor-Infiltrating Tissue-Resident Memory CD8 T Cells in Patients with Hepatocellular Carcinoma Receiving Immunotherapy. Shen YC; Yeh CP; Jeng YM; Hsu C; Hsu CH; Lin ZZ; Shao YY; Lu LC; Liu TH; Chen CH; Cheng AL Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680292 [TBL] [Abstract][Full Text] [Related]
29. Transcriptional Activity and Stability of CD39+CD103+CD8+ T Cells in Human High-Grade Endometrial Cancer. Workel HH; van Rooij N; Plat A; Spierings DCJ; Fehrmann RSN; Nijman HW; de Bruyn M Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471032 [TBL] [Abstract][Full Text] [Related]
30. Activated tissue resident memory T-cells (CD8+CD103+CD39+) uniquely predict survival in left sided "immune-hot" colorectal cancers. Talhouni S; Fadhil W; Mongan NP; Field L; Hunter K; Makhsous S; Maciel-Guerra A; Kaur N; Nestarenkaite A; Laurinavicius A; Willcox BE; Dottorini T; Spendlove I; Jackson AM; Ilyas M; Ramage JM Front Immunol; 2023; 14():1057292. PubMed ID: 37251410 [TBL] [Abstract][Full Text] [Related]
33. Paxillin Binding to the Cytoplasmic Domain of CD103 Promotes Cell Adhesion and Effector Functions for CD8 Gauthier L; Corgnac S; Boutet M; Gros G; Validire P; Bismuth G; Mami-Chouaib F Cancer Res; 2017 Dec; 77(24):7072-7082. PubMed ID: 29021139 [TBL] [Abstract][Full Text] [Related]
34. T cell interaction with activated endothelial cells primes for tissue-residency. Wienke J; Veldkamp SR; Struijf EM; Yousef Yengej FA; van der Wal MM; van Royen-Kerkhof A; van Wijk F Front Immunol; 2022; 13():827786. PubMed ID: 36172363 [TBL] [Abstract][Full Text] [Related]
35. Significance of CD103 Natsuki S; Tanaka H; Nishiyama M; Deguchi S; Miki Y; Yoshii M; Tamura T; Toyokawa T; Lee S; Maeda K BMC Cancer; 2023 Oct; 23(1):1011. PubMed ID: 37864146 [TBL] [Abstract][Full Text] [Related]
36. Differential Expression of CD49a and CD49b Determines Localization and Function of Tumor-Infiltrating CD8 Melssen MM; Lindsay RS; Stasiak K; Rodriguez AB; Briegel AM; Cyranowski S; Rutkowski MR; Conaway MR; Melief CJM; van der Burg SH; Eyo U; Slingluff CL; Engelhard VH Cancer Immunol Res; 2021 May; 9(5):583-597. PubMed ID: 33619119 [TBL] [Abstract][Full Text] [Related]
37. PD-1 and TIGIT coexpressing CD8 + CD103 + tissue-resident memory cells in endometrial cancer as potential targets for immunotherapy. Jiang F; Mao M; Jiang S; Jiao Y; Cao D; Xiang Y Int Immunopharmacol; 2024 Jan; 127():111381. PubMed ID: 38150880 [TBL] [Abstract][Full Text] [Related]
38. Tumor-Infiltrating CD103+ Tissue-Resident Memory T Cells and CD103-CD8+ T Cells in HNSCC Are Linked to Outcome in Primary but not Metastatic Disease. von Witzleben A; Ellis M; Thomas GJ; Hoffmann TK; Jackson R; Laban S; Ottensmeier CH Clin Cancer Res; 2024 Jan; 30(1):224-234. PubMed ID: 37874322 [TBL] [Abstract][Full Text] [Related]
39. Phenotypic Differences of CD103+ Tissue-Resident Memory T Cells Associated with Various Cancers. Park HS; Jeon Y; Lee H; Lee H; Kim YA; Park IA; Bang WS; Lee M; Cho YJ; Kim J; Gong G; Lee HJ Pathobiology; 2022; 89(2):116-126. PubMed ID: 34592745 [TBL] [Abstract][Full Text] [Related]